Skip to content

Nasopharyngeal Carcinoma Screening in Zhongshan City

Serology Screening Test for the Detection of Nasopharyngeal Carcinoma in Zhongshan City

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02501993
Enrollment
25000
Registered
2015-07-17
Start date
2012-03-31
Completion date
2023-12-31
Last updated
2023-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal Carcinoma

Brief summary

The primary objective is to determine the early diagnosis rate and mortality rate of the Nasopharyngeal Carcinoma (NPC) in the study population. The secondary objective is to determine the incidence of NPC in the study population.

Detailed description

The research is to evaluate the effect of NPC screening, also as an extended study of Screening for Nasopharyngeal Carcinoma in High Risk Populations (NCT00941538). The program was conducted in Xiaolan and Minzhong towns of Zhongshan city in 2012. All participants will be tested for anti-EBV antibody by using serum samples. Participants are stratified into those having high, moderate and low antibody levels, those having moderate antibody levels are invited to retest annually in the following 3 years and those found to have high antibody levels on these occasions are referred to centers for diagnostic workup for NPC.

Interventions

None listed

Sponsors

Zhongshan People's Hospital, Guangdong, China
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 59 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject residents in Zhongshan city * Subject is 30 to 59 years of age inclusive * Subject has no medical record of nasopharyngeal carcinoma * ECOG 0-2 * Subject has psychical condition and well consciousness * Subject is able to comprehend, sign, and date the written informed consent document to participate in the study.

Exclusion criteria

* Subject has heavy cardiovascular, liver or kidney disease * Subject has medical record of nasopharyngeal carcinoma * Subject who is not residing in Zhongshan City

Design outcomes

Primary

MeasureTime frame
The early detection rate (stage I and II) of Nasopharyngeal Carcinoma10 years
The mortality rate of Nasopharyngeal Carcinoma10 years

Secondary

MeasureTime frame
The incidence of Nasopharyngeal Carcinoma10 years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026